Psyched Wellness Latest Firm To Conduct Bought Deal Financing

Psyched Wellness (CSE: PSYC) is the latest psychedelics-focused firm to announce a bought deal financing, with the company this evening announcing a financing for $3.0 million. The financing is to be lead by Canaccord Genuity Corp of the behalf of a syndicate of underwriters.

The financing will see units of the company sold at a price of $0.31 per unit, with each unit containing one common share and one common share purchase warrant. Each warrant is valid for a period of three years from the date of issuance, with an exercise price of $0.43 per share.

Warrants issued under the offering are subject to an acceleration clause in the event that the equity trades above $0.70 for a period of five days on a volume weighted basis.

Proceeds from the financing are to be used to fully fund the pre-clinical trials of the firms Amanita Muscaria extract, and to continue the scientific research of the extract and its potential health benefits.

The financing is anticipated to close by February 12, 2021.

Psyched Wellness last traded at $0.36 on the CSE.


FULL DISCLOSURE: Psyched Wellness is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Psyched Wellness on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

2026 Could Be Gold’s Biggest Year Yet!? | Ryan King – Equinox Gold

Gold Is Screaming Higher While Currencies Burn | Simon Ridgway – Rackla Metals

We Have the Highest-Grade Antimony Deposit in North America!? | Jim Atkinson -Antimony Resources

Recommended

Canadian Copper Secures $8 Million Lead Order From Ocean Partners As Part Of Larger Funding Round

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Related News

Psyched Wellness To Conduct Stability Tests On Proprietary Mushroom Extract

Psyched Wellness (CSE: PSYC) is progressing with the development of its flagship product, an extract...

Monday, July 26, 2021, 09:28:00 AM

Psyched Wellness Adds Amanita Muscaria Expert To Advisory Board

Kevin Feeney has joined the advisory board of that of Psyched Wellness (CSE: PSYC) as...

Thursday, November 26, 2020, 07:16:39 AM

Psyched Wellness Moves To Next Stage Of Pre-Clinical Trials With Mushroom Extract

Psyched Wellness (CSE: PSYC) continues to execute on its strategy as it pertains to the...

Thursday, October 7, 2021, 08:21:06 AM

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

Today on the Daily Dive, Jeff Stevens returns to the show to sit down with...

Wednesday, December 30, 2020, 01:30:00 PM

Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the...

Thursday, October 22, 2020, 08:36:53 AM